Capocasa Marco, Anagnostou Paolo, D'Abramo Flavio, Matteucci Giulia, Dominici Valentina, Destro Bisol Giovanni, Rufo Fabrizio
Istituto Italiano di Antropologia, Rome, Italy.
Department of Environmental Biology, Sapienza University of Rome, Rome, Italy.
PeerJ. 2016 Feb 25;4:e1613. doi: 10.7717/peerj.1613. eCollection 2016.
Biobanks, which contain human biological samples and/or data, provide a crucial contribution to the progress of biomedical research. However, the effective and efficient use of biobank resources depends on their accessibility. In fact, making bio-resources promptly accessible to everybody may increase the benefits for society. Furthermore, optimizing their use and ensuring their quality will promote scientific creativity and, in general, contribute to the progress of bio-medical research. Although this has become a rather common belief, several laboratories are still secretive and continue to withhold samples and data. In this study, we conducted a questionnaire-based survey in order to investigate sample and data accessibility in research biobanks operating all over the world. The survey involved a total of 46 biobanks. Most of them gave permission to access their samples (95.7%) and data (85.4%), but free and unconditioned accessibility seemed not to be common practice. The analysis of the guidelines regarding the accessibility to resources of the biobanks that responded to the survey highlights three issues: (i) the request for applicants to explain what they would like to do with the resources requested; (ii) the role of funding, public or private, in the establishment of fruitful collaborations between biobanks and research labs; (iii) the request of co-authorship in order to give access to their data. These results suggest that economic and academic aspects are involved in determining the extent of sample and data sharing stored in biobanks. As a second step of this study, we investigated the reasons behind the high diversity of requirements to access biobank resources. The analysis of informative answers suggested that the different modalities of resource accessibility seem to be largely influenced by both social context and legislation of the countries where the biobanks operate.
生物样本库包含人类生物样本和/或数据,对生物医学研究的进展做出了至关重要的贡献。然而,生物样本库资源的有效和高效利用取决于其可及性。事实上,让生物资源能迅速被每个人获取可能会增加对社会的益处。此外,优化其使用并确保其质量将促进科学创造力,并总体上有助于生物医学研究的进展。尽管这已成为一种相当普遍的观念,但仍有一些实验室保密,继续保留样本和数据。在本研究中,我们进行了一项基于问卷的调查,以调查全球范围内运营的研究型生物样本库中样本和数据的可及性。该调查共涉及46个生物样本库。其中大多数允许访问其样本(95.7%)和数据(85.4%),但免费且无条件的可及性似乎并非普遍做法。对回复调查的生物样本库资源可及性指南的分析突出了三个问题:(i)要求申请者解释他们想用所申请的资源做什么;(ii)公共或私人资金在生物样本库与研究实验室之间建立富有成效的合作中的作用;(iii)为获取其数据而要求共同署名。这些结果表明,经济和学术方面都涉及到确定生物样本库中存储的样本和数据共享的程度。作为本研究的第二步,我们调查了获取生物样本库资源的要求高度多样化背后的原因。对信息性答案的分析表明,资源可及性的不同方式似乎在很大程度上受到生物样本库所在国家的社会背景和立法的影响。